Carbamazepine-induced hepatorenal failure in a child

Pharmacotherapy

Volumn 19, Issue 5, 1999, Pages 667-671

  Haase, Mark R ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; CARBAMAZEPINE; CEFIXIME; CEFUROXIME; CHOLESTEROL; CREATININE; DIAZEPAM; LACTATE DEHYDROGENASE; LAMOTRIGINE; LORAZEPAM; NITROGEN; PROTEIN; UREA; URIC ACID;

ARTICLE; CASE REPORT; CHILD; HEPATORENAL SYNDROME; HUMAN; MALE; RECTAL DRUG ADMINISTRATION; SEIZURE;

EID: 0032921888     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.8.667.31527     Document Type: Article

References (31)

1. Stremski ES, Brady WB, Prasad K, Hennes HA. Pediatric carbamazepine intoxication. Ann Emerg Med 1995;25(5): 624-30.
2. Pellock JM. Carbamazepine side effects in children and adults. Epilepsia 1987;28(suppl 3):S64-70.
3. Hadzic N, Portmann B, Davies ET, Mowat AP, Mieli-Vergani G. Acute liver failure induced by carbamazepine. Arch Dis Child 1990;65(3):315-17.
4. Brodie MJ, Dichter MA. Antiepileptic drugs. N Engl J Med 1996;334(3):168-75.
5. Askmark H, Wiholm B. Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system. Acta Neurol Scand 1990;81:131-40.
6. Hopen G, Nesthus I, Laerum OD. Fatal carbamazepine-associated hepatitis: report of two cases. Acta Med Scand 1981;210:333-5.
7. Horowitz S, Patwardhan R, Marcus E. Hepatotoxic reactions associated with carbamazepine therapy. Epilepsia 1988;29(2):149-54.
8. Kong KH. Carbamazepine-induced hepatitis in a patient with cervical myelopathy. Arch Phys Med Rehabil 1996;77:305-6.
9. Horowitz S, Patwarden R, Marcus E. Carbamazepine hepatotoxicity [letter]. Epilepsia 1986;27(5):592.
10. Hordon LD, Turney JH. Membranous glomerulopathy associated with carbamazepine [letter]. Br Med J 1987;294:375.
11. Hogg RJ, Sawyer M, Hecox K, Eigenbrodt E. Carbamazepine-induced acute tubulointerstitial nephritis. J Pediatr 1981;98(5):830-2.
12. Nicholls DP. Acute renal failure from carbamazepine [letter]. Br Med J 1972;25:490.
13. Murphy JV, Roberts CC, Francisco CB. Fulminant hepatorenal failure in two patients receiving carbamazepine [letter]. Ann Neurol 1989;26(3):458.
14. Viani F, Claris-Appiani A, Rossi LN, et al. Severe hepatorenal failure in a child receiving carbamazepine and erythromycin [letter]. Eur J Pediatr 1992;151:715.
15. Dreifuss FE, Langer DH. Hepatic considerations in the use of antiepileptic drugs. Epilepsia 1987;28(suppl 2):S23-9.
16. Gilman JT. Carbamazepine dosing for pediatric seizure disorders: the highs and lows. Ann Pharmacother 1991;25:1109-12.
17. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985;313:145-51.
18. Zucker P, Daum F, Cohen MI. Fatal carbamazepine hepatitis. J Pediatr 1977;91:667-8.
19. Herranz JL, Armijo JA, Arteaga R. Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproic acid during monotherapy in children. Epilepsia 1988;29(6):794-804.
20. Woody RC. Carbamazepine intoxication following the use of erythromycin in children. Pediatr Infect Dis J 1987;6(6):578-9.
21. Eknoyan G. Acute tubulointerstitial nephritis. In: Schrier RW, Gottschalk CW, eds. Diseases of the kidney, 6th ed. Boston: Little, Brown, 1997:1257-60.
22. Sobotka JL, Alexander B, Cook BL. A review of carbamazepine's hematologic reactions and monitoring recommendations. Ann Pharmacother 1990;24:1214-19.
23. Weig SG, Pollack P. Carbamazepine-induced heart block in a child with tuberous sclerosis and cardiac rhabdomyoma: implications for evaluation and follow-up. Ann Neurol 1993;34(4):617-19.
24. Kasarkis EJ, Kuo CS, Berger R, Nelson K. Carbamazepine-induced cardiac dysfunction: characterization of two distinct clinical syndromes. Arch Intern Med 1992;152:186-91.
25. Apfelbaum JD, Caravati EM, Kerns WP, Bossart PJ, Larsen G. Cardiovascular effects of carbamazepine toxicity. Ann Emerg Med 1995;25(5):631-5.
26. Bridge TA, Norton RL, Robertson WO. Pediatric carbamazepine overdoses. Pediatr Emerg Care 1994;10(5):260-3.
27. Salzman MB, Valderrama E, Sood SK. Carbamazepine and fatal eosinophilic myocarditis [letter]. N Engl J Med 1997;336(12):878-9.
28. Scully RE, Mark EJ, McNeely WF, Ebeling SH. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises. N Engl J Med 1996;335(8):577-84.
29. Keating A, Blahunka P. Carbamazepine-induced Stevens-Johnson syndrome in a child [letter]. Ann Pharmacother 1995;29:538-9.
30. Ray-Chaudhuri D, Pye IF, Boggild M. Hypersensitivity to carbamazepine presenting with a leukemoid reaction, eosinophilia, erythroderma, and renal failure. Neurology 1989;39:436-8.
31. Reiffers-Mettelock J, Hentges F, Humbel RL. Syndrome resembling systemic lupus erythematosus induced by carbamazepine [letter]. Dermatology 1997;195:306-7.